Whilst the events do not outline any new safety risks, the data gives a new understanding of the link between oncogenesis and ...

According to Lancet Public Health, the incidence of probable food allergy more than doubled in England between 2008 and 2018.

Eli Lilly and insitro said the deals offers a “new paradigm” for collaborations between major pharmaceutical companies and ...

Biogen plans to start a Phase III trial for felzartamab as a treatment for antibody-mediated rejection, and two other ...

As a risk factor for future serious health conditions, the early prevention, detection and management of type 2 diabetes are ...

At CPHI Europe, an expert discussed the promise of gummies as a drug delivery system and their unique manufacturing ...

Germany-based Merck KGaA has announced the launch of a new €290m ($317.6m) biosafety testing facility in Rockville, Maryland, ...

Arda Therapeutics has secured $43m in Series A financing led by Andreessen Horowitz to develop targeted cell depletion ...

Patient recruitment is a critical yet challenging phase in clinical trials. EMIS has been lauded for its significant ...

City Therapeutics has announced its launch, accompanied by a $135m Series A financing to lead advancements in RNA ...

The US FDA has declined to approve Zealand Pharma's dasiglucagon for hypoglycaemia in infants with congenital hyperinsulinism ...

ProductLife Group (PLG) has announced the acquisition of IntiQuan, a Swiss firm specialising in pharmacometrics. The move ...